Challenges Remain, But Research Abounds in Polycythemia Vera and Myelofibrosis
Published: Tuesday, Sep 03, 2019
David S. Snyder, MD
Treatment options for patients with polycythemia vera (PV) and myelofibrosis have remained stagnant within the past few years, but there have been novel agents moving through the pipeline, explained David S. Snyder, MD, adding that there is uncertainty whether any of them will replace the role of transplant.
... to read the full story